当前位置:
X-MOL 学术
›
Rheumatology
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Clinical course of pediatric-onset Behçet's Disease in young adulthood
Rheumatology ( IF 4.7 ) Pub Date : 2024-11-13 , DOI: 10.1093/rheumatology/keae624 Tugce Bozkurt, Mehmet Yıldız, Rabia Deniz, Ayten Yazıcı, Murat Karabacak, Hakan Karataş, Seda Kutluğ-Ağaçkıran, Aybüke Günalp, Elif Kılıç Könte, Sezgin Şahin, Oya Köker, Kenan Barut, Cemal Bes, Ayşe Cefle, Tulin Ergun, Haner Direskeneli, Özgür Kasapçopur, Fatma Alibaz-Oner
Rheumatology ( IF 4.7 ) Pub Date : 2024-11-13 , DOI: 10.1093/rheumatology/keae624 Tugce Bozkurt, Mehmet Yıldız, Rabia Deniz, Ayten Yazıcı, Murat Karabacak, Hakan Karataş, Seda Kutluğ-Ağaçkıran, Aybüke Günalp, Elif Kılıç Könte, Sezgin Şahin, Oya Köker, Kenan Barut, Cemal Bes, Ayşe Cefle, Tulin Ergun, Haner Direskeneli, Özgür Kasapçopur, Fatma Alibaz-Oner
Objectives Although Behçet's disease (BD) typically manifests in the second or third decade of life, initial symptoms may appear at a younger age. It may also take a longer time for the full disease phenotype to develop after the first symptom onset in pediatric patients. In this study we aimed to assess the clinical course of pediatric-onset BD in adulthood period. Methods The files of 112 patients diagnosed with BD before the age of 18, selected from five tertiary clinics, were retrospectively examined. Patients with a follow-up of less than six months were excluded. Results The study comprised 93 patients with pediatric-onset BD, of whom 64.5% (n = 60) were male. The median age of diagnosis was 15 years (13–17). Major organ involvement was present in 49 (52.5%) patients. The most commonly affected organ was the eye (29%). Sixty-eight (73.1%) patients had follow-up data in adulthood. Fourty patients had only mucocutaneous manifestations in the pediatric period. During follow-up in adulthood, 15 (53.3% were male) had new major organ involvement with a mean of 10.1 (SD: 7.9) years after diagnosis. Twenty-eight patients (41.1%) experienced major organ involvement during the pediatric period. In adulthood follow-up, 12 (42.8%) developed new major organ involvement and/or relapse of the same organ. Eighteen (26.5%) of 68 pediatric-onset BD patients had new major organ involvement, and 9 (13.2%) had a relapse during adulthood follow-up. Conclusion Our results showed that nearly one-third of pediatric BD patients have a new major organ involvement or a relapse in adulthood. Regular follow-up of pediatric BD patients in adulthood is essential to prevent long-term damage in this disease subset.
中文翻译:
儿童早期发病的白塞病的临床病程
目的 虽然白塞病 (BD) 通常在生命的第二个或第三个十年出现,但初始症状可能在年轻时出现。在儿科患者首次出现症状后,完整的疾病表型也可能需要更长的时间才能发展。在这项研究中,我们旨在评估成年期儿童发病 BD 的临床病程。方法 回顾性检查从 5 家三级诊所选育的 112 例 18 岁前诊断为 BD 的患者的档案。随访时间少于 6 个月的患者被排除在外。结果 该研究包括 93 例儿童发病的 BD 患者,其中 64.5% (n = 60) 为男性。中位诊断年龄为 15 岁 (13-17)。49 例 (52.5%) 患者存在主要器官受累。最常受影响的器官是眼睛 (29%)。68 例 (73.1%) 患者在成年后有随访数据。40 例患者在儿科期间仅出现皮肤黏膜表现。在成年期随访期间,15 例 (53.3% 为男性) 在诊断后平均 10.1 (SD: 7.9) 年出现新的主要器官受累。28 例患者 (41.1%) 在儿科期间经历了主要器官受累。在成年随访中,12 例 (42.8%) 出现新的主要器官受累和/或同一器官复发。68 例儿科发病的 BD 患者中有 18 例 (26.5%) 有新的主要器官受累,9 例 (13.2%) 在成年随访期间复发。结论 我们的结果显示,近 1/3 的儿科 BD 患者在成年后出现新发的主要器官受累或复发。成年后对儿科 BD 患者进行定期随访对于防止该疾病亚群的长期损害至关重要。
更新日期:2024-11-13
中文翻译:
儿童早期发病的白塞病的临床病程
目的 虽然白塞病 (BD) 通常在生命的第二个或第三个十年出现,但初始症状可能在年轻时出现。在儿科患者首次出现症状后,完整的疾病表型也可能需要更长的时间才能发展。在这项研究中,我们旨在评估成年期儿童发病 BD 的临床病程。方法 回顾性检查从 5 家三级诊所选育的 112 例 18 岁前诊断为 BD 的患者的档案。随访时间少于 6 个月的患者被排除在外。结果 该研究包括 93 例儿童发病的 BD 患者,其中 64.5% (n = 60) 为男性。中位诊断年龄为 15 岁 (13-17)。49 例 (52.5%) 患者存在主要器官受累。最常受影响的器官是眼睛 (29%)。68 例 (73.1%) 患者在成年后有随访数据。40 例患者在儿科期间仅出现皮肤黏膜表现。在成年期随访期间,15 例 (53.3% 为男性) 在诊断后平均 10.1 (SD: 7.9) 年出现新的主要器官受累。28 例患者 (41.1%) 在儿科期间经历了主要器官受累。在成年随访中,12 例 (42.8%) 出现新的主要器官受累和/或同一器官复发。68 例儿科发病的 BD 患者中有 18 例 (26.5%) 有新的主要器官受累,9 例 (13.2%) 在成年随访期间复发。结论 我们的结果显示,近 1/3 的儿科 BD 患者在成年后出现新发的主要器官受累或复发。成年后对儿科 BD 患者进行定期随访对于防止该疾病亚群的长期损害至关重要。